Anonymous ID: 1e6bf1 July 29, 2021, 7:53 p.m. No.14227164   🗄️.is 🔗kun   >>7176

Anonymous ID: 1e6bf1 July 29, 2021, 8:03 p.m. No.14227234   🗄️.is 🔗kun

>>14227176

Anonymous ID: 1e6bf1 July 29, 2021, 8:08 p.m. No.14227264   🗄️.is 🔗kun   >>7293

Anonymous ID: 1e6bf1 July 29, 2021, 8:11 p.m. No.14227298   🗄️.is 🔗kun

>>14227293

Anonymous ID: 1e6bf1 July 29, 2021, 8:28 p.m. No.14227415   🗄️.is 🔗kun

Anonymous ID: 1e6bf1 July 29, 2021, 8:38 p.m. No.14227485   🗄️.is 🔗kun

>>14227419

Covered this a few months ago when formulating the prevention protocol.

 

Toll Like Receptor 4 inhibition using a nasal spray with tetrahydrocurcumin inhibits TLr4 activity.

 

https://www.hindawi.com/journals/mi/2021/8874339/

Anonymous ID: 1e6bf1 July 29, 2021, 8:48 p.m. No.14227552   🗄️.is 🔗kun   >>7622

>>14227542

Anonymous ID: 1e6bf1 July 29, 2021, 8:52 p.m. No.14227577   🗄️.is 🔗kun

>>14227559

Anonymous ID: 1e6bf1 July 29, 2021, 8:55 p.m. No.14227610   🗄️.is 🔗kun   >>7630

>>14227592

Anonymous ID: 1e6bf1 July 29, 2021, 9 p.m. No.14227649   🗄️.is 🔗kun

>>14227630